In the context of cancer, IL-1 signalling promotes tumour progression by upregulating matrix metalloproteinases, stimulating pro-angiogenic mediators such as VEGF and prostaglandin E2, and enhancing adhesion molecule expression on endothelial cells, which facilitates tumour cell extravasation and metastasis. This evidence concerns the gene IL1B and neoplasm.